OGEN ORAGENICS INC Management Changes 8-K Filing 2025 - Management Changes Oragenics appointed Janet Huffman as Interim CEO with a 10% salary increase to $275,000 and reported the resignation of director Bruce Cassidy; all Pre-Funded Warrants from a September 2024 offering have been exercised, resulting in 13,709,805 shares outstanding.Get access to all SEC 8-K filings of the ORAGENICS INC